Latest filing published 22 May 2020 for Abeona Therapeutics INC..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -68.6%Entry US$191.00 · Close at T+365 US$60.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen B. Howell: trading record in brief
Stephen B. Howell discloses dealings in Abeona Therapeutics Inc. to SEC (Form 4). Over a trading history stretching from 23 January 2012 to 20 May 2020, the count stands at 4 filings.
On the market, this insider has only ever bought: 1 purchase, €28k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants.
The latest filing, published on 22 May 2020, reports a share grant in Abeona Therapeutics Inc. The latest purchase dates back some time: it was published 2,770 days ago, on 10 April 2019. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen B. Howell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,969 shares0Common StockSEC:0001493152-20-009760:0
- 300 shares0Common stockSEC:0001144204-19-027766:0
- 75,000 shares0Common stockSEC:0001144204-19-027766:1
- 4,000 shares@ US$7.77100.0% of flowCommon stockSEC:0001144204-19-019115:0Canonical exit: 7 Jul 2019 (T+90)
4 of 4 declarations
